{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:34:49Z","timestamp":1792164889881,"version":"4.4.0"},"reference-count":358,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.4158\/ep.17.3.456","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:58:31Z","timestamp":1365202711000},"page":"456-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":410,"title":["Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists"],"prefix":"10.1016","volume":"17","author":[{"given":"Rebecca S.","family":"Bahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry B.","family":"Burch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carol","family":"Greenlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Laurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Ross","family":"McDougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Montori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Rivkees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Ann","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius N.","family":"Stan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.17.3.456_bb0010","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.1995.03520340064038","article-title":"(American Thyroid Association Standards of Care Committee). Treatment guidelines for patients with hyperthyroidism and hypothyroidism","volume":"273","author":"Singer","year":"1995","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4158\/1934-2403-8.6.457","article-title":"(American Association of Clinical Endocrinologists). American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism","volume":"8","author":"Baskin","year":"2002","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.17.3.456_bb0020","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"(GRADE Working Group). Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.4158\/EP.17.3.456_bb0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","article-title":"Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force","volume":"129","author":"Guyatt","year":"2006","journal-title":"Chest"},{"key":"10.4158\/EP.17.3.456_bb0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4158\/EP.16.2.270","article-title":"(American Association of Clinical Endocrinologists). American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines-2010 update","volume":"16","author":"Mechanick","year":"2010","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.17.3.456_bb0035","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","article-title":"A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-9343(90)90178-G","article-title":"Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter","volume":"89","author":"Berghout","year":"1990","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mce.2010.02.001","article-title":"Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism","volume":"322","author":"Gozu","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5694\/j.1326-5377.1996.tb94135.x","article-title":"Hyperthyroidism in elderly hospitalised patients. Clinical features and outcome","volume":"164","author":"Martin","year":"1996","journal-title":"Med J Aust"},{"key":"10.4158\/EP.17.3.456_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005792-197405000-00001","article-title":"Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients","volume":"53","author":"Davis","year":"1974","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/EP.17.3.456_bb0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0002-9343(86)90547-4","article-title":"Thyrotoxicosis in the very old","volume":"81","author":"Tibaldi","year":"1986","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2796.1991.tb00368.x","volume":"229","author":"Laurberg","year":"1991","journal-title":"J Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1210\/jcem-67-4-656","article-title":"Lasting remissions in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease","volume":"67","author":"Codaccioni","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/jech.37.3.245","article-title":"Aetiology of hyperthyroidism in Canada and Wales","volume":"37","author":"Williams","year":"1983","journal-title":"J Epidemiol Community Health"},{"key":"10.4158\/EP.17.3.456_bb0080","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/archinte.1990.00390190063008","article-title":"How common is postpartum thyroiditis? A methodologic overview of the literature","volume":"150","author":"Gerstein","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2001.01381.x","article-title":"Association between lithium use and thyrotoxicosis caused by silent thyroiditis","volume":"55","author":"Miller","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0002-9343(96)00259-8","article-title":"Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha","volume":"101","author":"Roti","year":"1996","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinology"},{"key":"10.4158\/EP.17.3.456_bb0100","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2002-021799","article-title":"Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study","volume":"88","author":"Fatourechi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0105","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.4158\/EP.17.3.456_bb0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening hyperthyroidism: Thyroid storm","volume":"22","author":"Burch","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP.17.3.456_bb0115","first-page":"230","article-title":"Mortality in patients treated for hyperthyroidism with iodine-131","volume":"128","author":"Hall","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4158\/EP.17.3.456_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0163-8343(88)90084-9","article-title":"A psychiatric and neuropsychological study of patients with untreated Graves' disease","volume":"10","author":"Trzepacz","year":"1988","journal-title":"Gen Hosp Psychiatry"},{"key":"10.4158\/EP.17.3.456_bb0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0002-9343(89)80614-X","article-title":"Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms","volume":"87","author":"Trzepacz","year":"1989","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb0130","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1210\/jc.2009-2495","article-title":"Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study","volume":"95","author":"Boelaert","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00019616-199409000-00010","article-title":"Beta-adrenergic receptor blocking drugs in the management of hyperthyroidism","volume":"4","author":"Ventrella","year":"1994","journal-title":"Endocrinologist"},{"key":"10.4158\/EP.17.3.456_bb0140","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","volume":"48","author":"European Heart Rhythm Association; Heart Rhythm Society","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"10.4158\/EP.17.3.456_bb0145","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2006-1074","article-title":"Changes in skeletal muscle protein metabolism and myosin heavy chain isoform messenger ribonucleic acid abundance after treatment of hyperthyroidism","volume":"91","author":"Brennan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0150","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.1989.00390030032006","article-title":"Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients","volume":"149","author":"de los Santos","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jcem-70-2-453","article-title":"Applications of a new chemiluminometric thyrotropin assay to subnormal measurement","volume":"70","author":"Spencer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF03348351","article-title":"Euthyroid hyperthyroxinemia","volume":"6","author":"Rajatanavin","year":"1983","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP.17.3.456_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jcem-61-1-17","article-title":"Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma","volume":"61","author":"Rajatanavin","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1530\/eje.0.1480433","article-title":"The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients","volume":"148","author":"Socin","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb0175","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/0003-4819-123-8-199510150-00002","article-title":"Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study","volume":"123","author":"Brucker-Davis","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0180","first-page":"273","article-title":"Diagnostic imaging in thyrotoxicosis","volume":"24","author":"Summaria","year":"1999","journal-title":"Rays"},{"key":"10.4158\/EP.17.3.456_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ncpendmet0692","article-title":"Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease?","volume":"4","author":"Bogazzi","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jcem-65-2-359","article-title":"Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels","volume":"65","author":"Shigemasa","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1210\/edrv-1-4-411","article-title":"Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis?","volume":"1","author":"Woolf","year":"1980","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.17.3.456_bb0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM198208123070705","article-title":"Low serum thyroglobulin as a clue to the diagnosis of hyperthyroidism factitia","volume":"307","author":"Mariotti","year":"1982","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/thy.1993.3.101","article-title":"The measurement of fecal thyroxine in the diagnosis of thyrotoxicosis factitia","volume":"3","author":"Bouillon","year":"1993","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0210","first-page":"90","article-title":"Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease","volume":"84","author":"Costagliola","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2006-924979","article-title":"Does autoantibody-negative Graves' disease exist? A second evaluation of the clinical diagnosis","volume":"38","author":"Paunkovic","year":"2006","journal-title":"Horm Met Res"},{"key":"10.4158\/EP.17.3.456_bb0220","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2265.2001.01347.x","article-title":"TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays","volume":"55","author":"Pedersen","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb0225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-121-4-199408150-00010","article-title":"Treatment of hyperthyroid disease","volume":"121","author":"Klein","year":"1994","journal-title":"Ann Int Med"},{"key":"10.4158\/EP.17.3.456_bb0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States","volume":"1","author":"Wartofsky","year":"1991","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0235","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/thy.2005.15.1279","article-title":"Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery","volume":"15","author":"Abraham-Nordling","year":"2005","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0240","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00003081-198312000-00005","article-title":"Appendicitis in pregnancy","volume":"26","author":"Weingold","year":"1983","journal-title":"Clin Obstet Gynecol"},{"key":"10.4158\/EP.17.3.456_bb0245","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archsurg.2009.48","article-title":"Outcomes following thyroid and parathyroid surgery in pregnant women","volume":"144","author":"Kuy","year":"2009","journal-title":"Arch Surg"},{"key":"10.4158\/EP.17.3.456_bb0250","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-Associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"Tr\u00e4isk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9343(83)91217-2","article-title":"Radioiodine-induced thyroid storm. Case report and literature review","volume":"75","author":"McDermott","year":"1983","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb0260","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bmj.39114.670150.BE","article-title":"Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials","volume":"334","author":"Walter","year":"2007","journal-title":"BMJ"},{"key":"10.4158\/EP.17.3.456_bb0265","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1001\/jama.1961.03040170008003","article-title":"Thyrocardiac disease and its management with radioactive iodine I-131","volume":"176","author":"Delit","year":"1961","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb0270","first-page":"3016","article-title":"The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease","volume":"86","author":"Burch","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0275","first-page":"4012","article-title":"Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism","volume":"84","author":"Andrade","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0280","series-title":"Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine,","first-page":"2033","article-title":"Endocrine disorders and cardiovascular disease","author":"Klein","year":"2008"},{"key":"10.4158\/EP.17.3.456_bb0285","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199803123381103","article-title":"Mortality after the treatment of hyperthyroidism with radioactive iodine","volume":"338","author":"Franklyn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb0290","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(76)90419-0","article-title":"Lithium as an adjunct to radioiodine therapy for thyrotoxicosis","volume":"1","author":"Turner","year":"1976","journal-title":"Lancet"},{"key":"10.4158\/EP.17.3.456_bb0295","first-page":"499","article-title":"Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism","volume":"84","author":"Bogazzi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0300","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/jc.2009-1655","article-title":"Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0305","first-page":"180","article-title":"The increasing incidence of hypothyroidism within one year after radioiodine therapy for toxic diffuse goiter","volume":"19","author":"Von Hofe","year":"1978","journal-title":"J Nucl Med"},{"key":"10.4158\/EP.17.3.456_bb0310","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2362.1995.tb01547.x","article-title":"Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity. Results from a prospective, randomized, multicentre study","volume":"25","author":"Peters","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"10.4158\/EP.17.3.456_bb0315","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.2002-020805","article-title":"A randomized comparison of radioiodine doses in Graves' hyperthyroidism","volume":"88","author":"Leslie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/thy.1998.8.393","article-title":"Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter","volume":"8","author":"Jarl\u00f8v","year":"1998","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0325","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2362.1996.98243.x","article-title":"Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study","volume":"26","author":"Peters","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.4158\/EP.17.3.456_bb0330","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/thy.1997.7.247","article-title":"Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study","volume":"7","author":"Peters","year":"1997","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0335","first-page":"3058","article-title":"Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy","volume":"85","author":"Kaptein","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0340","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/1050725041517093","article-title":"Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease","volume":"14","author":"Santos","year":"2004","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0345","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.280.4.347","article-title":"Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group","volume":"280","author":"Ron","year":"1998","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb0350","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1210\/jcem-22-1-8","article-title":"Thyroid nodules occurring late after treatment of thryotoxicosis with radioiodine","volume":"22","author":"Sheline","year":"1962","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0355","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3476(05)81640-3","article-title":"Elementary school performance of children with congenital hypothyroidism.","volume":"116","author":"New England Congenital Hypothyroidism Collaborative","year":"1990","journal-title":"J Pediatr."},{"key":"10.4158\/EP.17.3.456_bb0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.294.1.71","article-title":"Thyroid function and mortality in patients treated for hyperthyroidism","volume":"294","author":"Franklyn","year":"2005","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb0365","first-page":"2283","article-title":"Cancer mortality in women with thyroid disease","volume":"50","author":"Goldman","year":"1990","journal-title":"Cancer Res"},{"key":"10.4158\/EP.17.3.456_bb0370","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/83.15.1072","article-title":"Cancer risk after iodine-131 therapy for hyperthyroidism","volume":"83","author":"Holm","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.4158\/EP.17.3.456_bb0375","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/cncr.22635","article-title":"Increased cancer incidence after radioiodine treatment for hyperthyroidism","volume":"109","author":"Metso","year":"2007","journal-title":"Cancer"},{"key":"10.4158\/EP.17.3.456_bb0380","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2265.2006.02613.x","article-title":"Testicular function after 131I therapy for hyperthyroidism","volume":"65","author":"Ceccarelli","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb0385","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-3476(63)80080-3","article-title":"Congenital hypothyroidism in infant following maternal I-131 therapy with a review of hazards of environmental radioisotope contamination","volume":"62","author":"Fisher","year":"1963","journal-title":"J Pediatr"},{"key":"10.4158\/EP.17.3.456_bb0390","first-page":"357","article-title":"Radioiodine treatment of hyperthyroidism in a pregnant women","volume":"39","author":"Berg","year":"1998","journal-title":"J Nucl Med"},{"key":"10.4158\/EP.17.3.456_bb0395","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF03178671","article-title":"Radiation protection recommendations for I-131 thyrotoxicosis, thyroid cancer and phaeochromocytoma patients","volume":"27","author":"Woodings","year":"2004","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.4158\/EP.17.3.456_bb0400","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9343(99)80137-5","article-title":"Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease","volume":"99","author":"Uy","year":"1995","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb0405","doi-asserted-by":"crossref","unstructured":"Alexander EK, Larsen PR. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab. 2022;87:1073-1077.","DOI":"10.1210\/jcem.87.3.8333"},{"key":"10.4158\/EP.17.3.456_bb0410","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb0415","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-102-3-328","article-title":"Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance","volume":"102","author":"Cooper","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0420","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1210\/jc.2003-030185","article-title":"Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies","volume":"88","author":"Cooper","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0425","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.1.01993","article-title":"A systematic review of drug therapy for Graves' hyperthyroidism","volume":"153","author":"Abraham","year":"2005","journal-title":"Eur J Endorinol"},{"key":"10.4158\/EP.17.3.456_bb0430","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0435","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03344959","article-title":"Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature","volume":"17","author":"Meyer-Gessner","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP.17.3.456_bb0440","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3904\/kjim.2006.21.4.240","article-title":"Diffuse alveolar hemorrhage associated with antineutrophil cytoplasmic antibody levels in a pregnant woman taking propylthiouracil","volume":"21","author":"Kang","year":"2006","journal-title":"Korean J Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0445","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1210\/jc.2008-2700","article-title":"Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs","volume":"94","author":"Noh","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0450","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1742-1241.2006.01250.x","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil","volume":"63","author":"Cin","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.4158\/EP.17.3.456_bb0455","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1420587","article-title":"Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication","volume":"142","author":"Gunton","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb0460","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/106002800303700213","article-title":"Fulminant hepatic failure associated with propylthiouracil","volume":"37","author":"Ruiz","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.4158\/EP.17.3.456_bb0465","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0470","unstructured":"U.S. Food and Drug Administration. Information for Healthcare Professionals - Propylthiouracil-Induced Liver Failure. June 4, 2009. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm162701.htm"},{"key":"10.4158\/EP.17.3.456_bb0475","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1345\/aph.1G720","article-title":"Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole","volume":"40","author":"Vilchez","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.4158\/EP.17.3.456_bb0480","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4158\/EP.8.3.222","article-title":"Methimazole-induced hepatotoxicity","volume":"8","author":"Woeber","year":"2002","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.17.3.456_bb0485","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0028-3886.27165","article-title":"Aplasia cutis congenita of the scalp: therapeutic modalities","volume":"54","author":"Shivakumar","year":"2006","journal-title":"Neurol India"},{"key":"10.4158\/EP.17.3.456_bb0490","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archotol.132.9.1009","article-title":"Antenatal carbimazole and choanal atresia: a new embryopathy","volume":"132","author":"Wolf","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.4158\/EP.17.3.456_bb0495","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007691-200608000-00001","article-title":"Pharmacokinetics and pharmacotherapy of thionamides in pregnancy","volume":"28","author":"Clark","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.4158\/EP.17.3.456_bb0500","unstructured":"Ross DS. Patient information: Antithyroid drugs. UpToDate. Available at: http:\/\/www.uptodate.com\/patients\/content\/topic.do?topicKey=~K7dgOAIby0pAB7&source=see_link"},{"key":"10.4158\/EP.17.3.456_bb0505","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring","volume":"150","author":"Tajiri","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0510","first-page":"1","article-title":"ANCA-positive vasculitis in a patient with Graves' disease: cross-reaction between Propylthiouracil and Methimazole","volume":"9","author":"Ahmed","year":"2010","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.17.3.456_bb0515","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-118-6-199303150-00005","article-title":"Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study","volume":"118","author":"Liaw","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0520","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.3748\/wjg.v12.i38.6232","article-title":"Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring?","volume":"12","author":"Benyounes","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.4158\/EP.17.3.456_bb0525","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1572-0241.2001.03469.x","article-title":"The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study","volume":"96","author":"Kim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.4158\/EP.17.3.456_bb0530","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease","volume":"92","author":"Nakamura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0535","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/archinte.1980.00330200060021","article-title":"Propylthiouracil-induced hepatic damage","volume":"140","author":"Weiss","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0540","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4158\/EP.4.4.197","article-title":"Successful outcome with methimazole and lithium combination therapy for propylthiouracil-induced hepatotoxicity","volume":"4","author":"Waseem","year":"1998","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.17.3.456_bb0545","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF03346433","article-title":"Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study","volume":"31","author":"Mazza","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP.17.3.456_bb0550","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF03343979","article-title":"Does smoking increase relapse rates in Graves' disease?","volume":"25","author":"Kimball","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP.17.3.456_bb0555","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0560","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1470583","article-title":"Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease","volume":"147","author":"Nedrebo","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb0565","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2362.2004.01318.x","article-title":"Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawal","volume":"34","author":"Orunesu","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.4158\/EP.17.3.456_bb0570","first-page":"307","article-title":"Remission of Graves' hyperthyroidism treated with methimazole","volume":"54","author":"Bolanos","year":"2002","journal-title":"Rev Invest Clin"},{"key":"10.4158\/EP.17.3.456_bb0575","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/105072502761016467","article-title":"Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease","volume":"12","author":"Orgiazzi","year":"2002","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0580","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/eje.0.1440475","volume":"144","author":"Glinoer","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb0585","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.2000.10.891","article-title":"Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment","volume":"10","author":"Takasu","year":"2000","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0590","first-page":"39","article-title":"Goitre size and outcome of medical treatment of Graves' disease","volume":"111","author":"Laurberg","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4158\/EP.17.3.456_bb0595","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2007-0229","article-title":"Effect of Lugol solution on thyroid gland, blood flow and micovessel density in patients with Graves' disease","volume":"92","author":"Erbil","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0600","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1072-7515(00)00755-9","article-title":"Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter","volume":"191","author":"Ansaldo","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.4158\/EP.17.3.456_bb0605","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2265.1991.tb03562.x","article-title":"Rapid preoperative preparation in hyperthyroidism","volume":"35","author":"Baeza","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb0610","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/jsre.2000.5875","article-title":"The efficacy of thyroidectomy for Graves' disease: A meta-analysis","volume":"90","author":"Palit","year":"2000","journal-title":"J Surg Res"},{"key":"10.4158\/EP.17.3.456_bb0615","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jamcollsurg.2007.11.023","article-title":"A population based study of outcomes from thyroidectomy in aging Americans: at what cost?","volume":"206","author":"Sosa","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.4158\/EP.17.3.456_bb0620","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199809000-00005","article-title":"The importance of surgeon experience for clinical and economic outcomes from thyroidectomy","volume":"228","author":"Sosa","year":"1998","journal-title":"Ann Surg"},{"key":"10.4158\/EP.17.3.456_bb0625","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s001040050757","article-title":"Complications in thyroid surgery. Incidence and therapy [in German]","volume":"70","author":"R\u00f6her","year":"1999","journal-title":"Chirurg"},{"key":"10.4158\/EP.17.3.456_bb0630","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hed.1076","article-title":"Re-operation for bleeding after thyroidectomy and parathyroidectomy","volume":"23","author":"Abbas","year":"2001","journal-title":"Head Neck"},{"key":"10.4158\/EP.17.3.456_bb0635","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2044.2003.03410.x","article-title":"Consent and anaesthetic risk","volume":"58","author":"Jenkins","year":"2003","journal-title":"Anaesthesia"},{"key":"10.4158\/EP.17.3.456_bb0640","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1067\/mhn.2002.127891","article-title":"Predicting calcium status post-thyroidectomy with early calcium levels","volume":"127","author":"Husein","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.4158\/EP.17.3.456_bb0645","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1445-2197.2007.04183.x","article-title":"Parathyroid hormone assay predicts hypocalcaemia after total thyroidectomy","volume":"77","author":"Sywak","year":"2007","journal-title":"ANZ J Surg"},{"key":"10.4158\/EP.17.3.456_bb0650","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00268-009-0348-0","article-title":"An algorithm informed by the parathyroid hormone level reduces hypocalcemic complications of thyroidectomy","volume":"34","author":"Wiseman","year":"2010","journal-title":"World J Surg"},{"key":"10.4158\/EP.17.3.456_bb0655","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.otohns.2009.08.026","article-title":"The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia","volume":"141","author":"Sabour","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.4158\/EP.17.3.456_bb0660","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/hed.21199","article-title":"Prediction of hypocalcemia after using 1- to 6-hour postoperative parathyroid hormone and calcium levels: an analysis of pooled individual patient data from 3 observational studies","volume":"32","author":"Jumaily","year":"2010","journal-title":"Head Neck"},{"key":"10.4158\/EP.17.3.456_bb0665","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/thy.2006.16.259","article-title":"The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy","volume":"16","author":"McLeod","year":"2006","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0670","unstructured":"Kaplan EL, Angelos P. Surgery of the Thyroid Gland. Thyroid Disease Manager. Available at: http:\/\/www.thyroidmanager.org\/Chapter21\/21-frame.htm"},{"key":"10.4158\/EP.17.3.456_bb0675","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jamcollsurg.2007.06.298","article-title":"Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies","volume":"205","author":"Noordzij","year":"2007","journal-title":"J Am Coll Surg"},{"key":"10.4158\/EP.17.3.456_bb0680","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.otohns.2007.11.021","article-title":"Cost savings associated with post-thyroidectomy parathyroid hormone levels","volume":"138","author":"Cote","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.4158\/EP.17.3.456_bb0685","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1067\/msy.2002.128617","article-title":"Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy?","volume":"132","author":"Bellantone","year":"2002","journal-title":"Surgery"},{"key":"10.4158\/EP.17.3.456_bb0690","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s002689910116","article-title":"Hypomagnesemia and hypocalcemia after thyroidectomy: prospective study","volume":"24","author":"Wilson","year":"2000","journal-title":"World J Surg"},{"key":"10.4158\/EP.17.3.456_bb0695","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.amjsurg.2006.03.010","article-title":"Routine oral calcium and vitamin D supplements for prevention of hypocalcemia after total thyroidectomy","volume":"192","author":"Roh","year":"2006","journal-title":"Am J Surg"},{"key":"10.4158\/EP.17.3.456_bb0700","first-page":"205","article-title":"Thyroid cancer yield in patients with Graves' disease","volume":"28","author":"Stocker","year":"2003","journal-title":"Minerva Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb0705","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/bjs.5279","article-title":"Prognosis of small thyroid cancer in patients with Graves' disease","volume":"93","author":"Kikuchi","year":"2006","journal-title":"Br J Surg"},{"key":"10.4158\/EP.17.3.456_bb0710","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejrad.2007.03.015","article-title":"The role of imaging in Graves' disease: a cost-effectiveness analysis","volume":"65","author":"Cappelli","year":"2007","journal-title":"Eur J Radiol"},{"key":"10.4158\/EP.17.3.456_bb0715","first-page":"96","article-title":"Incidental thyroid carcinoma in thyrotoxic patients treated by surgery","volume":"67","author":"Cakir","year":"2007","journal-title":"Horm Res"},{"key":"10.4158\/EP.17.3.456_bb0720","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.","volume":"19","author":"American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Cancer","year":"2009","journal-title":"Thyroid."},{"key":"10.4158\/EP.17.3.456_bb0725","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4158\/EP.16.3.468","volume":"16","author":"Gharib","year":"2010","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.17.3.456_bb0730","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ecl.2006.09.008","article-title":"Thyrotoxicosis and thyroid storm","volume":"35","author":"Nayak","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP.17.3.456_bb0735","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2265.1988.tb01217.x","article-title":"Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease","volume":"28","author":"Roti","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb0740","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/thy.1998.8.277","article-title":"Treatment of patients with toxic multinodular goiter","volume":"8","author":"Erickson","year":"1998","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0745","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1067\/msy.2002.128691","article-title":"Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine","volume":"132","author":"Kang","year":"2002","journal-title":"Surgery"},{"key":"10.4158\/EP.17.3.456_bb0750","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/archinte.159.12.1364","article-title":"Radioiodine therapy for multinodular toxic goiter","volume":"159","author":"Nygaard","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb0755","first-page":"103","article-title":"Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism","volume":"23","author":"Holm","year":"1982","journal-title":"J Nucl Med"},{"key":"10.4158\/EP.17.3.456_bb0760","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/thy.2004.14.933","article-title":"Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis","volume":"14","author":"Vidal-Trecan","year":"2004","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0765","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2265.1999.00635.x","article-title":"Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules","volume":"50","author":"Nygaard","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb0770","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.otohns.2007.09.015","article-title":"Hypothyroidism following partial thyroidectomy","volume":"138","author":"Vaiman","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.4158\/EP.17.3.456_bb0775","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2265.2005.02218.x","article-title":"Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study","volume":"62","author":"Ceccarelli","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb0780","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJM198312153092401","article-title":"Follow-up of solitary autonomous thyroid nodules treated with 131I","volume":"309","author":"Goldstein","year":"1983","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb0785","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s00268-008-9566-0","article-title":"Evidence-based management of toxic multinodular goiter (Plummer's Disease)","volume":"32","author":"Porterfield","year":"2008","journal-title":"World J of Surg"},{"key":"10.4158\/EP.17.3.456_bb0790","first-page":"3636","article-title":"The feasibility of high dose iodine 131 as an alternative to surgery in patients with a very large goiter; effect on thyroid function and size and pulmonary function","volume":"84","author":"Bonnema","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0795","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1055\/s-0029-1212064","article-title":"Differentiated operative therapy of thyroid autonomy (Plummer's disease)","volume":"106","author":"Wahl","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.4158\/EP.17.3.456_bb0800","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/BF03348807","article-title":"Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease","volume":"15","author":"van Soestbergen","year":"1992","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP.17.3.456_bb0805","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/thy.1999.9.477","article-title":"Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by I131 therapy","volume":"9","author":"Nygaard","year":"1999","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0810","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ijc.2910500611","article-title":"Cancer mortality after iodine-131 therapy for hyperthyroidism","volume":"50","author":"Hall","year":"1992","journal-title":"Int J Cancer"},{"key":"10.4158\/EP.17.3.456_bb0815","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0001-2998(71)81039-5","article-title":"Complications of radioiodine treatment of hyperthyroidism","volume":"1","author":"Becker","year":"1971","journal-title":"Semin Nucl Med"},{"key":"10.4158\/EP.17.3.456_bb0820","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4158\/EP.14.7.832","article-title":"Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters","volume":"14","author":"Braverman","year":"2008","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.17.3.456_bb0825","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0300-2977(99)00066-2","article-title":"Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs","volume":"55","author":"Koornstra","year":"1999","journal-title":"Neth J Med"},{"key":"10.4158\/EP.17.3.456_bb0830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0022-3859.33855","article-title":"Thyroid cancer in toxic and non-toxic multinodular goiter","volume":"53","author":"Cerci","year":"2007","journal-title":"J Postgrad Med"},{"key":"10.4158\/EP.17.3.456_bb0835","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/eje.0.1350383","article-title":"Treatment of the autonomous thyroid nodule: a review","volume":"135","author":"Ferrari","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb0840","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1517\/13543780802501325","article-title":"Thiamazole as an adjuvant to radioiodine for volume reduction of multinodular goiter","volume":"17","author":"Albino","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.4158\/EP.17.3.456_bb0845","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMc0807896","article-title":"Problems associated with the use of thyrogen in patients with a thyroid gland","volume":"359","author":"Magner","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb0850","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MNM.0b013e3283169148","article-title":"Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule","volume":"30","author":"Zakavi","year":"2009","journal-title":"Nucl Med Commun"},{"key":"10.4158\/EP.17.3.456_bb0855","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01561498","article-title":"Prevention and management of hyperthyroid storm","volume":"2","author":"Dobyns","year":"1978","journal-title":"World J Surg"},{"key":"10.4158\/EP.17.3.456_bb0860","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2044.1984.tb07273.x","article-title":"Beta-adrenoceptor blockade and anaesthesia for thyroidectomy","volume":"39","author":"Hamilton","year":"1984","journal-title":"Anaesthesia"},{"key":"10.4158\/EP.17.3.456_bb0865","series-title":"Anesthesia.","first-page":"795","article-title":"Risk of anesthesia","author":"\u2018Fleisher","year":"2000"},{"key":"10.4158\/EP.17.3.456_bb0870","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jamcollsurg.2005.04.034","article-title":"Thyroidectomy using local anesthesia: a report of 1,025 cases over 16 years","volume":"201","author":"Spanknebel","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.4158\/EP.17.3.456_bb0875","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0889-8529(05)70304-2","article-title":"Toxic nodular goiter: Toxic adenoma and toxic multinodular goiter","volume":"27","author":"Siegel","year":"1998","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.4158\/EP.17.3.456_bb0880","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/00000658-198712000-00016","article-title":"Total thyroidectomy. The preferred option for multinodular goiter","volume":"203","author":"Reeve","year":"1987","journal-title":"Ann Surg"},{"key":"10.4158\/EP.17.3.456_bb0885","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s002680020100","article-title":"Total thyroidectomy for benign thyroid disorders in an endemic region","volume":"25","author":"Mishra","year":"2001","journal-title":"World J Surg"},{"key":"10.4158\/EP.17.3.456_bb0890","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/110241598750005840","article-title":"Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports","volume":"164","author":"Pappalardo","year":"1998","journal-title":"Eur J Surg"},{"key":"10.4158\/EP.17.3.456_bb0895","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/110241501750243725","article-title":"Total thyroidectomy: the procedure of choice for multinodular goitre","volume":"167","author":"Hisham","year":"2001","journal-title":"Eur J Surg"},{"key":"10.4158\/EP.17.3.456_bb0900","first-page":"13","article-title":"Experience in a specialist thyroid surgery unit; a demographic study, surgical complications, and outcome","volume":"163","author":"al-Suliman","year":"1997","journal-title":"Eur J Surg"},{"key":"10.4158\/EP.17.3.456_bb0905","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s002680010221","article-title":"Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany","volume":"24","author":"Thomusch","year":"2000","journal-title":"World J Surg"},{"key":"10.4158\/EP.17.3.456_bb0910","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ageing\/28.4.363","article-title":"Age is no contraindication to thyroid surgery","volume":"28","author":"Bliss","year":"1999","journal-title":"Age Ageing"},{"key":"10.4158\/EP.17.3.456_bb0915","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/SLA.0b013e31812eecc4","article-title":"Racial disparities in clinical and economic outcomes from thyroidectomy","volume":"246","author":"Sosa","year":"2007","journal-title":"Ann Surg"},{"key":"10.4158\/EP.17.3.456_bb0920","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-0029-1212076","article-title":"The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goiter compared to radioiodine therapy with different doses","volume":"107","author":"Tak\u00e1ts","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.4158\/EP.17.3.456_bb0925","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2214\/AJR.07.2668","article-title":"Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients","volume":"190","author":"Tarantino","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.4158\/EP.17.3.456_bb0930","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.d01-1752.x","article-title":"Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients","volume":"46","author":"Monzani","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb0935","first-page":"207","article-title":"Percutaneous ethanol injection plus radioiodine versus radioiodine along in the treatment of large toxic thyroid nodules","volume":"44","author":"Zingrillo","year":"2003","journal-title":"J Nucl Med"},{"key":"10.4158\/EP.17.3.456_bb0940","first-page":"CD006294","article-title":"Radioiodine treatment for pediatric Graves' disease","volume":"16","author":"Ma","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP.17.3.456_bb0945","first-page":"3767","article-title":"Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment","volume":"83","author":"Rivkees","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0950","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3949\/ccjm.55.4.373","article-title":"Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment","volume":"55","author":"Levy","year":"1988","journal-title":"Cleve Clin J Med"},{"key":"10.4158\/EP.17.3.456_bb0955","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jc.2006-1238","article-title":"The optimal treatment for pediatric Graves' disease is surgery","volume":"92","author":"Lee","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0960","first-page":"847","article-title":"Iodine-131: optimal therapy for hyperthyroidism in children and adolescents?","volume":"20","author":"Freitas","year":"1979","journal-title":"J Nucl Med"},{"key":"10.4158\/EP.17.3.456_bb0965","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jama.295.9.1060","article-title":"Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl","volume":"295","author":"Boice","year":"2006","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb0970","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jnci\/dji151","article-title":"Radiation-induced thyroid cancer-what's new?","volume":"97","author":"Boice","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.4158\/EP.17.3.456_bb0975","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1210\/jc.2008-0660","article-title":"Clinical and economic outcomes of thyroid and parathyroid surgery in children","volume":"93","author":"Sosa","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb0980","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.surg.2008.08.033","article-title":"Pediatric endocrine surgery: who is operating on our children?","volume":"144","author":"Tuggle","year":"2008","journal-title":"Surgery"},{"key":"10.4158\/EP.17.3.456_bb0985","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00007611-199509000-00018","article-title":"Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism","volume":"88","author":"Nicholas","year":"1995","journal-title":"South Med J"},{"key":"10.4158\/EP.17.3.456_bb0990","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/thy.2006.0193","article-title":"Treatment for childhood-onset Graves' disease in Japan: results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists","volume":"17","author":"Sato","year":"2007","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb0995","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2265.2005.02415.x","article-title":"Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study","volume":"64","author":"Cassio","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1000","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00128072-200305020-00003","article-title":"Graves disease in childhood: a review of the options for diagnosis and treatment","volume":"5","author":"D\u00f6tsch","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.4158\/EP.17.3.456_bb1005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/JPEM.2000.13.7.879","article-title":"Diagnosis and management of juvenile hyperthyroidism in Germany: a retrospective multicenter study","volume":"13","author":"D\u00f6tsch","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1515\/JPEM.1999.12.4.537","article-title":"Factors at onset predictive of lasting remission in pediatric patients with Graves' disease followed for at least three years","volume":"12","author":"Mussa","year":"1999","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/eje.0.1310467","article-title":"Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study","volume":"131","author":"Perrild","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1515\/JPEM.2005.18.6.597","article-title":"Effective methimazole dose for childhood Grave's disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery","volume":"18","author":"Slyper","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1025","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1089\/thy.2007.0072","article-title":"Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication","volume":"17","author":"Smith","year":"2007","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1030","first-page":"CD003420","article-title":"Antithyroid drug regimen for treating Graves' hyperthyroidism","volume":"18","author":"Abraham","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP.17.3.456_bb1035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02169","article-title":"What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease","volume":"154","author":"Razvi","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","article-title":"Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose","volume":"98","author":"Cooper","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1045","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMc0809750","article-title":"Ending propylthiouracil-induced liver failure in children","volume":"360","author":"Rivkees","year":"2009","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb1050","doi-asserted-by":"crossref","unstructured":"Rivkees SA, Mattison DR. Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use. Intl J Pediatr Endocrinol. 2009; 132041.","DOI":"10.1186\/1687-9856-2009-132041"},{"key":"10.4158\/EP.17.3.456_bb1055","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development. Hepatic Toxicity Following Treatment for Pediatric Graves' Disease Meeting on October 28, 2008. Available at: http:\/\/bpca.nichd.nih.gov\/collaborativeefforts\/upload\/Hepatic-Toxicity-10-28-08-final-final-01-09-09.pdf"},{"key":"10.4158\/EP.17.3.456_bb1060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-137-9-200211050-00035","article-title":"Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis","volume":"137","author":"Salpeter","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1065","doi-asserted-by":"crossref","first-page":"176970","DOI":"10.1186\/1687-9856-2010-176970","article-title":"Adverse events associated with methimazole therapy of graves' disease in children","volume":"2010","author":"Rivkees","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1070","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/jcem-60-5-1019","article-title":"Management of hyperthyroidism in children and adolescents","volume":"60","author":"Hamburger","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1075","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jc.2008-0842","article-title":"Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment","volume":"93","author":"Kaguelidou","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/thy.2005.15.292","article-title":"Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?","volume":"15","author":"Tajiri","year":"2005","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1085","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1210\/jcem.85.10.6922","article-title":"Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients","volume":"85","author":"Lazar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpendmet0068","article-title":"Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission?","volume":"2","author":"Weetman","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1095","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1542\/peds.2007-1535","article-title":"(Organization of Pediatric Endocrinologists of Northern California Collaborative Graves' Disease Study Group). Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study","volume":"121","author":"Glaser","year":"2008","journal-title":"Pediatrics"},{"key":"10.4158\/EP.17.3.456_bb1100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/thy.1997.7.755","article-title":"Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy","volume":"7","author":"Shulman","year":"1997","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1105","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1210\/jcem-64-6-1241","article-title":"Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years","volume":"64","author":"Lippe","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1110","first-page":"1719","article-title":"Predictors of early remission of hyperthyroidism in children","volume":"82","author":"Glaser","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1120","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1210\/jcem.86.5.7473","article-title":"Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication","volume":"86","author":"Kadmon","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1542\/peds.111.4.745","article-title":"Influence of iodine-131 dose on the outcome of hyperthyroidism in children","volume":"111","author":"Rivkees","year":"2003","journal-title":"Pediatrics"},{"key":"10.4158\/EP.17.3.456_bb1130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/eje.0.1490485","article-title":"Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial","volume":"149","author":"Bonnema","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1067\/mpd.2002.125494","article-title":"Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children","volume":"141","author":"Nebesio","year":"2002","journal-title":"J Pediatr"},{"key":"10.4158\/EP.17.3.456_bb1140","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jcem-38-6-976","article-title":"Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study","volume":"38","author":"Dobyns","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1145","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/028418698430520","article-title":"Radiation and thyroid cancer: what more can be learned?","volume":"37","author":"Boice","year":"1998","journal-title":"ACTA Oncol"},{"key":"10.4158\/EP.17.3.456_bb1150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00004032-196809000-00002","article-title":"The risk of thyroid cancers following irradiation","volume":"15","author":"Dolphin","year":"1968","journal-title":"Health Phys"},{"key":"10.4158\/EP.17.3.456_bb1155","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1210\/jc.2006-1239","article-title":"An optimal treatment for pediatric Graves' disease is radioiodine","volume":"92","author":"Rivkees","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1160","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcu.1870180602","article-title":"Normal volume of the thyroid gland in children","volume":"18","author":"Ueda","year":"1990","journal-title":"J Clin Ultrasound"},{"key":"10.4158\/EP.17.3.456_bb1165","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/jc.2002-021801","article-title":"How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism?","volume":"88","author":"Kalinyak","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1170","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/JPEM.2006.19.9.1095","article-title":"The treatment of Graves' disease in children","volume":"19","author":"Rivkees","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1175","first-page":"953","article-title":"Graves' disease therapy in children: truth and inevitable consequences","volume":"20","author":"Rivkees","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2307\/3579003","article-title":"Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies","volume":"141","author":"Ron","year":"1995","journal-title":"Radiat Res"},{"key":"10.4158\/EP.17.3.456_bb1185","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0140-6736(05)66695-0","article-title":"Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study","volume":"365","author":"Sigurdson","year":"2005","journal-title":"Lancet"},{"key":"10.4158\/EP.17.3.456_bb1190","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1001\/jama.292.21.2600","article-title":"(Hanford Thyroid Disease Study Team). Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site","volume":"292","author":"Davis","year":"2004","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb1195","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ijc.11258","article-title":"Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden","volume":"106","author":"Dickman","year":"2003","journal-title":"Int J Cancer"},{"key":"10.4158\/EP.17.3.456_bb1200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2307\/3578322","article-title":"Issues and epidemiological evidence regarding radiation-induced thyroid cancer","volume":"131","author":"Shore","year":"1992","journal-title":"Radiat Res"},{"key":"10.4158\/EP.17.3.456_bb1205","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jc.2003-031223","article-title":"A 36 year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients","volume":"89","author":"Read","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1148\/radiographics.20.2.g00mc33533","article-title":"The AAPM\/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications","volume":"20","author":"Toohey","year":"2000","journal-title":"Radiographics"},{"key":"10.4158\/EP.17.3.456_bb1215","series-title":"Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII - Phase 2","author":"Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation, Board on Radiation Effects, Division on Earth and Life Studies, National Research Council of the National Academies","year":"2006"},{"key":"10.4158\/EP.17.3.456_bb1220","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0039-6060(96)80049-3","article-title":"Surgical treatment of Graves' disease: subtotal or total thyroidectomy?","volume":"120","author":"Miccoli","year":"1996","journal-title":"Surgery"},{"key":"10.4158\/EP.17.3.456_bb1225","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.surg.2006.07.040","article-title":"Surgical management of Graves disease in childhood and adolescence: an institutional experience","volume":"140","author":"Sherman","year":"2006","journal-title":"Surgery"},{"key":"10.4158\/EP.17.3.456_bb1230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1235","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000071713","article-title":"Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management","volume":"49","author":"Diez","year":"2003","journal-title":"Gerontology"},{"key":"10.4158\/EP.17.3.456_bb1240","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/EJE-07-0877","article-title":"Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005","volume":"158","author":"Abraham-Nordling","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1245","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/jcem-73-4-843","article-title":"Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression","volume":"73","author":"Lewis","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1250","first-page":"1130","article-title":"Complex alteration of thyroid function in healthy centenarians","volume":"77","author":"Mariotti","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2265.1991.tb01739.x","article-title":"Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom","volume":"34","author":"Parle","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1260","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/BF03346431","article-title":"Prevalence and causes of undiagnosed hyperthyroidism in an adult healthy population. The Troms\u00f8 study","volume":"31","author":"Bj\u00f8rndal","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP.17.3.456_bb1265","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archinte.167.14.1533","article-title":"Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians","volume":"167","author":"Meyerovitch","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1270","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/thy.2005.15.687","article-title":"Observations concerning the natural history of subclinical hyperthyroidism","volume":"15","author":"Woeber","year":"2005","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1275","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb1280","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk, and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb1285","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1210\/jc.2002-021046","article-title":"The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities","volume":"88","author":"Sgarbi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1290","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/eje.0.1450391","article-title":"Haemodynamic changes following treatment of subclinical and overt hyperthyroidism","volume":"145","author":"Faber","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1295","first-page":"4701","article-title":"Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients","volume":"85","author":"Biondi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-134-7-200104030-00009","article-title":"(Study of Osteoporotic Fractures Research Group). Risk for fracture in women with low serum levels of thyroid-stimulating hormone","volume":"134","author":"Bauer","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1305","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2265.1994.tb02571.x","article-title":"Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism","volume":"41","author":"Muddle","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1310","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2265.1998.00427.x","article-title":"Normalization of serum thyrotropin by mean of radioiodine treatment in subclinical hyperthyroidism: effect of bone loss in postmenopausal women","volume":"48","author":"Faber","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1315","first-page":"4157","article-title":"Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism","volume":"85","author":"Kumeda","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1320","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.maturitas.2004.02.017","article-title":"Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism","volume":"48","author":"Tauchmanov\u00e0","year":"2004","journal-title":"Maturitas"},{"key":"10.4158\/EP.17.3.456_bb1325","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/thy.2006.16.375","article-title":"The impact of overt and subclinical hyperthyroidism on skeletal muscle","volume":"16","author":"Brennan","year":"2006","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1330","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2009-1625","article-title":"Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy","volume":"95","author":"Flynn","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1335","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-145-8-200610170-00006","article-title":"Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction?","volume":"145","author":"Roberts","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1340","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.292.21.2591","article-title":"Thyroid status, disability and cognitive function, and survival in old age","volume":"292","author":"Gussekloo","year":"2004","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb1345","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-2265.2000.01146.x","article-title":"Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study","volume":"53","author":"Kalmijn","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1350","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1532-5415.2008.02080.x","article-title":"Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study","volume":"57","author":"Ceresini","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.4158\/EP.17.3.456_bb1355","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archinte.1991.00400010159025","article-title":"Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism","volume":"151","author":"Sawin","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1360","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"key":"10.4158\/EP.17.3.456_bb1365","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archinte.167.14.1526","article-title":"Association between increased mortality and mild thyroid dysfunction in cardiac patients","volume":"167","author":"Iervasi","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1370","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2265.2006.02619.x","article-title":"Subclinical thyroid dysfunction and blood pressure: a community-based study","volume":"65","author":"Walsh","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1375","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-08-0110","article-title":"Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies","volume":"159","author":"Haentjens","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1380","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-148-11-200806030-00225","article-title":"Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality","volume":"148","author":"Ochs","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1385","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks","year":"2004","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb1390","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4158\/EP.14.8.973","article-title":"Changes in body composition in women following treatment of overt and subclinical hyperthyroidism","volume":"14","author":"Greenlund","year":"2008","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.17.3.456_bb1395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-08-0663","article-title":"Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy","volume":"160","author":"Laurberg","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1400","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1056\/NEJM199410203311608","article-title":"Maternal and fetal thyroid function","volume":"331","author":"Burrow","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb1405","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1210\/edrv.18.3.0300","article-title":"The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology","volume":"18","author":"Glinoer","year":"1997","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.17.3.456_bb1410","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1210\/jc.2008-1461","article-title":"The role of human chorionic gonadotropin as a thyroid stimulator in normal pregnancy","volume":"93","author":"Hershman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1415","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1089\/thy.2004.14.1084","article-title":"Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency","volume":"14","author":"Soldin","year":"2004","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/thy.2005.15.44","article-title":"Are detection and treatment of thyroid insufficiency in pregnancy feasible?","volume":"15","author":"Mandel","year":"2005","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1425","first-page":"531","article-title":"A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy","volume":"101","author":"Weeke","year":"1982","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4158\/EP.17.3.456_bb1430","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1089\/thy.2004.14.1030","article-title":"The nature of analogue-based free thyroxine estimates","volume":"14","author":"Nelson","year":"2004","journal-title":"Thyroid"},{"issue":"260","key":"10.4158\/EP.17.3.456_bb1435","first-page":"e1","article-title":"Free T4 immunoassays are flawed during pregnancy","volume":"200","author":"Lee","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.4158\/EP.17.3.456_bb1440","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.clinbiochem.2008.04.009","article-title":"Free thyroxine reference interval in each trimester of pregnancy determined with the Roche Modular E-170 electrochemiluminescent immunoassay","volume":"41","author":"Gong","year":"2008","journal-title":"Clin Biochem"},{"key":"10.4158\/EP.17.3.456_bb1445","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.clinbiochem.2008.12.004","article-title":"Method specific second-trimester reference intervals for thyroid-stimulating hormone and free thyroxine","volume":"42","author":"Silvio","year":"2009","journal-title":"Clin Biochem"},{"key":"10.4158\/EP.17.3.456_bb1450","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.AOG.0000197991.64246.9a","article-title":"Subclinical hyperthyroidism and pregnancy outcomes","volume":"107","author":"Casey","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP.17.3.456_bb1455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9378(89)90088-4","article-title":"Thyrotoxicosis complicating pregnancy","volume":"160","author":"Davis","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.4158\/EP.17.3.456_bb1460","first-page":"946","article-title":"Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism","volume":"84","author":"Millar","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP.17.3.456_bb1465","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0028-2243(94)90276-3","article-title":"Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy","volume":"54","author":"Kriplani","year":"1994","journal-title":"Eur J Obstet Gynecol Reprod Bio"},{"key":"10.4158\/EP.17.3.456_bb1470","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2265.2008.03192.x","article-title":"Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study","volume":"69","author":"Vos","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1475","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/thy.1999.9.705","article-title":"Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease","volume":"9","author":"Amino","year":"1999","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1480","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2265.1990.tb00850.x","article-title":"Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function","volume":"32","author":"Mortimer","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1485","first-page":"3633","article-title":"Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism","volume":"82","author":"Momotani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1490","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1530\/eje.0.1390584","article-title":"Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association","volume":"139","author":"Laurberg","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1495","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1542\/peds.47.3.510","article-title":"Iodide goiter in the newborn","volume":"47","author":"Senior","year":"1971","journal-title":"Pediatrics"},{"key":"10.4158\/EP.17.3.456_bb1500","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00003081-198312000-00011","article-title":"Surgery of the endocrine glands in pregnancy","volume":"26","author":"Geelhoed","year":"1983","journal-title":"Clin Obstet Gynecol"},{"key":"10.4158\/EP.17.3.456_bb1505","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00019616-199112000-00009","article-title":"Thyrotoxicosis in pregnancy","volume":"1","author":"Seeley","year":"1991","journal-title":"Endocrinologist"},{"key":"10.4158\/EP.17.3.456_bb1510","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/ncpendmet0508","article-title":"Therapy insight: management of Graves' disease during pregnancy","volume":"3","author":"Chan","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1515","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jcem-57-5-1036","article-title":"Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism","volume":"57","author":"Zakarija","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1520","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.beem.2004.03.009","article-title":"Fetal and neonatal thyroid function in relation to maternal Graves' disease","volume":"18","author":"Polak","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1525","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/eje.0.1460275","article-title":"Post-partum thyroiditis-a clinical update","volume":"146","author":"Roti","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1530","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1210\/jc.2002-020524","article-title":"Clinical review 152: Postpartum thyroiditis","volume":"87","author":"Stagnaro-Green","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1535","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1530\/eje.0.1390036","article-title":"Prediction of post partum thyroid dysfunction: can it be improved?","volume":"139","author":"Kuijpens","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1540","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/thy.1999.9.721","article-title":"Radioiodine and pregnancy","volume":"9","author":"Gorman","year":"1999","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1545","doi-asserted-by":"crossref","first-page":"F249","DOI":"10.1136\/adc.2007.135764","article-title":"Meta-variability of advice on drugs in the breastfeeding mother: the example of beta-blockers","volume":"93","author":"Davanzo","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.4158\/EP.17.3.456_bb1550","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"New Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb1555","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.4158\/EP.17.3.456_bb1560","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1565","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1570","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/archinte.1980.00330200106028","article-title":"Racial differences in normal values of proptosis","volume":"140","author":"de Juan","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1575","first-page":"679","article-title":"Proptosis in normal Thai samples and thyroid patients","volume":"90","author":"Sarinnapakorn","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"10.4158\/EP.17.3.456_bb1580","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.eye.6701925","article-title":"Exophthalmos of patients with GD in Chinese of Taiwan","volume":"20","author":"Tsai","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.4158\/EP.17.3.456_bb1585","first-page":"368","article-title":"Quality of life in patients with Graves ophthalmopathy","volume":"103","author":"Yeatts","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.4158\/EP.17.3.456_bb1590","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.82.7.773","article-title":"Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL","volume":"82","author":"Terwee","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.4158\/EP.17.3.456_bb1595","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb1600","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb1605","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1610","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1530\/eje.0.1300494","article-title":"Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?","volume":"130","author":"Tallstedt","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1615","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archinte.1990.00390170124027","article-title":"Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy","volume":"150","author":"Prummel","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1620","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy","volume":"90","author":"Perros","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1625","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9343(89)80485-1","article-title":"Treatment of Graves' disease and the course of ophthalmopathy","volume":"87","author":"Sridama","year":"1989","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb1630","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","article-title":"Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption","volume":"45","author":"Pfeilschifter","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1635","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1503\/cmaj.070256","article-title":"Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials","volume":"179","author":"Eisenberg","year":"2008","journal-title":"CMAJ"},{"key":"10.4158\/EP.17.3.456_bb1640","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.299.17.2083","article-title":"A clinical blueprint to accelerate the elimination of tobacco use","volume":"299","author":"Fiore","year":"2008","journal-title":"JAMA"},{"key":"10.4158\/EP.17.3.456_bb1645","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jc.2009-2130","article-title":"Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study","volume":"95","author":"Lai","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1650","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/bjs.1800800921","article-title":"Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy","volume":"80","author":"Fern\u00e1ndez S\u00e1nchez","year":"1993","journal-title":"Br J Surg"},{"key":"10.4158\/EP.17.3.456_bb1655","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/thy.2005.15.1157","article-title":"Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection","volume":"15","author":"J\u00e4rhult","year":"2005","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1660","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2478\/v10035-007-0026-6","article-title":"Influence of total thyroidectomy on orbital opthalmopathy and levels of antithyroid antibodies in patients with Graves' disease","volume":"79","author":"Domoslawski","year":"2007","journal-title":"Polski Przeglad Chirurgiczny"},{"key":"10.4158\/EP.17.3.456_bb1665","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1210\/jc.2009-0506","article-title":"Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis","volume":"94","author":"Vannucchi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1670","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199512213332507","article-title":"Drugs and thyroid function","volume":"333","author":"Surks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb1675","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1530\/eje.0.1400264","article-title":"Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects","volume":"140","author":"Hintze","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.17.3.456_bb1680","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9343(93)90235-H","article-title":"Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly","volume":"95","author":"Martin","year":"1993","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb1685","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/thy.1996.6.107","article-title":"A prospective study of the effect of nonionic contrast media on thyroid function","volume":"6","author":"Conn","year":"1996","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1690","first-page":"928","article-title":"Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism","volume":"76","author":"Roti","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198301000-00001","article-title":"Iodide-induced thyrotoxicosis","volume":"62","author":"Fradkin","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"10.4158\/EP.17.3.456_bb1700","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2004-0627","article-title":"Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects","volume":"89","author":"Carella","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1705","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/105072503322238809","article-title":"Interferon-alpha and autoimmune thyroid disease","volume":"13","author":"Prummel","year":"2003","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1710","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.1997.7.891","article-title":"Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature","volume":"7","author":"Koh","year":"1997","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1715","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am J Med"},{"key":"10.4158\/EP.17.3.456_bb1720","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00019616-199905000-00008","article-title":"Amiodarone-induced thyroid dysfunction","volume":"9","author":"udica-Souza","year":"1999","journal-title":"Endocrinologist"},{"key":"10.4158\/EP.17.3.456_bb1725","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Enviromental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Int Med"},{"key":"10.4158\/EP.17.3.456_bb1730","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","article-title":"Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography","volume":"56","author":"Eaton","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.17.3.456_bb1735","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study","volume":"81","author":"Bartalena","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.17.3.456_bb1740","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/105072503321319521","article-title":"A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis","volume":"13","author":"Erdogan","year":"2003","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1745","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00268-004-7599-6","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience","volume":"28","author":"Houghton","year":"2004","journal-title":"World J Surg"},{"key":"10.4158\/EP.17.3.456_bb1750","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/105072502760143926","article-title":"Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique","volume":"12","author":"Williams","year":"2002","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1755","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/archinte.142.13.2281","article-title":"Treatment of lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis)","volume":"142","author":"Nikolai","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.17.3.456_bb1760","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/BF03349213","article-title":"A case of acute suppurative thyroiditis complicated by thyrotoxicosis","volume":"29","author":"Sicilia","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP.17.3.456_bb1765","first-page":"610","article-title":"Thyrotropin-secreting pituitary tumors","volume":"17","author":"Beck-Peccoz","year":"1996","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.17.3.456_bb1770","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0889-8529(05)70305-4","article-title":"Syndromes of thyrotoxicosis with low radioactive iodine uptake","volume":"27","author":"Ross","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP.17.3.456_bb1775","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/pgmj.66.772.132","article-title":"Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves' disease","volume":"66","author":"Kung","year":"1990","journal-title":"Postgrad Med J"},{"key":"10.4158\/EP.17.3.456_bb1780","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/thy.1999.9.653","article-title":"Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors","volume":"9","author":"Hershman","year":"1999","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1785","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/thy.2000.10.611","article-title":"Thyrotoxicosis in a male patient associated with excess human chorionic gonadotropin production by germ cell tumor","volume":"10","author":"Goodarzi","year":"2000","journal-title":"Thyroid"},{"key":"10.4158\/EP.17.3.456_bb1790","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM198704163161605","article-title":"An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef","volume":"316","author":"Hedberg","year":"1987","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.17.3.456_bb1795","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2265.1994.tb03942.x","article-title":"Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases","volume":"40","author":"Kasagi","year":"1994","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/Q707415233782R31.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:52:33Z","timestamp":1761515553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20404185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":358,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1530891X20404185"],"URL":"https:\/\/doi.org\/10.4158\/ep.17.3.456","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.17.3.456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}